Drug profile · INN
vancomycin
VANCOCIN
vancomycin (VANCOCIN) is a peptidoglycan inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: intravenous, oral. Current US regulatory status: approved.
Drug details — vancomycin
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS, ORAL
- Patents
- 20
- Programs
- 15
- Data quality
- 0.84
Quick answer
vancomycin (VANCOCIN) is a peptidoglycan inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: intravenous, oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Peptidoglycan inhibitor
Primary target: Peptidoglycan
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12409197
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 12083151
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11918612
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11701394
Compositions and methods for treating cholestatic disease
granted -
US 11666612
Network-based microbial compositions and methods
granted -
US 11464812
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11458174
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11458173
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11389490
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11266699
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 10973861
Compositions and methods
granted -
US 10967011
Compositions and methods
granted -
US 10881696
Network-based microbial compositions and methods
granted -
US 10864235
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 10258655
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 10076546
Network-based microbial compositions and methods
granted -
US 10064901
Compositions and methods
granted -
US 9855303
Compositions and methods
granted -
US 9585921
Compositions and methods
granted -
US 9533014
Synergistic bacterial compositions and methods of production and use thereof
granted
Frequently asked questions
What is vancomycin?
vancomycin (VANCOCIN) is a peptidoglycan inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: intravenous, oral. Current US regulatory status: approved.
What is the brand name for vancomycin?
VANCOCIN is a marketed brand name for vancomycin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vancomycin?
vancomycin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.